These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38015752)

  • 1. Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001-2016.
    Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):314-324. PubMed ID: 38015752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time - An Australian population-based record linkage study, 2001-2016.
    Lord SJ; Kiely BE; O'Connell DL; Daniels B; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N
    Eur J Cancer; 2024 Jan; 197():113468. PubMed ID: 38061215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: a population-based health record linkage study protocol.
    Lord SJ; Kiely BE; Pearson SA; Daniels B; O'Connell DL; Beith J; Bulsara MK; Houssami N
    BMJ Open; 2019 Feb; 9(2):e026414. PubMed ID: 30709862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
    Kunkler IH; Williams LJ; Jack WJ; Cameron DA; Dixon JM;
    Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of time to death after distant recurrence in breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term risk of distant metastasis in women with non-metastatic breast cancer and survival after metastasis detection: a population-based linked health records study.
    Lord SSJ; Daniels B; Kiely BE; O'Connell DL; Beith J; Pearson S; Chiew KL; Bulsara MK; Houssami N
    Med J Aust; 2022 Oct; 217(8):402-409. PubMed ID: 35987521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
    Litvak A; Batukbhai B; Russell SD; Tsai HL; Rosner GL; Jeter SC; Armstrong D; Emens LA; Fetting J; Wolff AC; Silhy R; Stearns V; Connolly RM
    Cancer; 2018 May; 124(9):1904-1911. PubMed ID: 29381193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990-2011.
    Malmgren J; Hurlbert M; Atwood M; Kaplan HG
    Breast Cancer Res Treat; 2019 Apr; 174(2):505-514. PubMed ID: 30560462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
    Aebi S; Gelber S; Anderson SJ; Láng I; Robidoux A; Martín M; Nortier JW; Paterson AH; Rimawi MF; Cañada JM; Thürlimann B; Murray E; Mamounas EP; Geyer CE; Price KN; Coates AS; Gelber RD; Rastogi P; Wolmark N; Wapnir IL;
    Lancet Oncol; 2014 Feb; 15(2):156-63. PubMed ID: 24439313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.
    Kunkler IH; Williams LJ; Jack WJL; Cameron DA; Dixon JM
    N Engl J Med; 2023 Feb; 388(7):585-594. PubMed ID: 36791159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
    Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
    Mamounas EP; Liu Q; Paik S; Baehner FL; Tang G; Jeong JH; Kim SR; Butler SM; Jamshidian F; Cherbavaz DB; Sing AP; Shak S; Julian TB; Lembersky BC; Wickerham DL; Costantino JP; Wolmark N
    J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstruction in Women with T4 Breast Cancer after Neoadjuvant Chemotherapy: When Is It Safe?
    Pawloski KR; Barrio AV; Gemignani ML; Sevilimedu V; Le T; Dayan J; Morrow M; Tadros AB
    J Am Coll Surg; 2021 Aug; 233(2):285-293. PubMed ID: 33957258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Tajiri W; Ijichi H; Takizawa K; Koi Y; Masuda T; Ueo H; Koga C; Nakamura Y; Taguchi K; Okamoto M; Tokunaga E
    Breast Cancer; 2021 Jan; 28(1):67-74. PubMed ID: 32601800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis.
    Lord SJ; Marinovich ML; Patterson JA; Wilcken N; Kiely BE; Gebski V; Crossing S; Roder DM; Gattellari M; Houssami N
    Med J Aust; 2012 Jun; 196(11):688-92. PubMed ID: 22708766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit.
    Gibberd A; Supramaniam R; Dillon A; Armstrong BK; O'Connell DL
    BMC Cancer; 2016 Apr; 16():289. PubMed ID: 27112140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
    Laurberg T; Tramm T; Nielsen T; Alsner J; Nord S; Myhre S; Sørlie T; Leung S; Fan C; Perou C; Gelmon K; Overgaard J; Voduc D; Prat A; Cheang MCU
    Acta Oncol; 2018 Jan; 57(1):38-43. PubMed ID: 29172851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.